ME Therapeutics Holding (FRA:Q9T) LT-Debt-to-Total-Asset : 0.04 (As of Nov. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. ME Therapeutics Holding's long-term debt to total assests ratio for the quarter that ended in Nov. 2024 was 0.04.

ME Therapeutics Holding's long-term debt to total assets ratio increased from Nov. 2023 (0.00) to Nov. 2024 (0.04). It may suggest that ME Therapeutics Holding is progressively becoming more dependent on debt to grow their business.

ME Therapeutics Holding LT-Debt-to-Total-Asset Historical Data

The historical data trend for ME Therapeutics Holding's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding LT-Debt-to-Total-Asset Chart

ME Therapeutics Holding Annual Data

Trend

Aug22

Aug23

Aug24

LT-Debt-to-Total-Asset

0.59

ME Therapeutics Holding Quarterly Data
	Aug22	Dec22	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial				-	-	-	-	0.04

ME Therapeutics Holding LT-Debt-to-Total-Asset Calculation

ME Therapeutics Holding's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Aug. 2024 is calculated as

LT Debt to Total Assets (A: Aug. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Aug. 2024 )	/	Total Assets (A: Aug. 2024 )
	=	0	/	1.022
	=

ME Therapeutics Holding's Long-Term Debt to Total Asset Ratio for the quarter that ended in Nov. 2024 is calculated as

LT Debt to Total Assets (Q: Nov. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Nov. 2024 )	/	Total Assets (Q: Nov. 2024 )
	=	0.038	/	1.052
	=

ME Therapeutics Holding (FRA:Q9T) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

ME Therapeutics Holding LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (FRA:Q9T) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

METX:Canada

Address

177 Robson St., Vancouver, BC, CAN, V6B 0N3

Website

https://www.metherapeutics.com

ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding Headlines

No Headlines